As such, high protein levels of YB-1 and MTA1 in PIN may predispose patients to a more aggressive prostate cancer when it develops, thereby increasing the risk for PSA recurrence or the need for future therapy after a prostatectomy. This evidence concerns the gene MTA1 and prostate intraepithelial neoplasia.